Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226338 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects
A Phase 1 study, sponsored by InventisBio Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT05226338 is a Phase 1 study that has completed, run by InventisBio Co.. The registered enrollment target is 18 participants.
The verdict
NCT05226338, a Phase 1 study, has completed, sponsored by InventisBio Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
Relative Bioavailability study of D-0502 tablet formulation in healthy female subjects
Interventions
- DRUG D-0502
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-10-27 |
| Est. Completion | 2022-05-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05226338
The ClinicalTrials.gov registry entry for NCT05226338 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InventisBio Co., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D-0502 is the first listed.
NCT05226338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05226338 about?
NCT05226338 is a clinical study titled "Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects". Relative Bioavailability study of D-0502 tablet formulation in healthy female subjects
What is the current status of trial NCT05226338?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2021-10-27. Estimated completion is 2022-05-11.
What interventions are being tested in trial NCT05226338?
The interventions under investigation include: D-0502 (DRUG).
Who is sponsoring clinical trial NCT05226338?
This trial is sponsored by InventisBio Co., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.